Restructuring and Related Charges	9 Months Ended
Mar. 31, 2023
Restructuring And Related Activities [Abstract]
Restructuring and Related Charges	14. Restructuring and Related Charges The Company recorded $1.4 million and $2.3 million of restructuring and related charges during the three and nine months ended March 31, 2023, respectively, which primarily included additional facilities charges related to previously impaired facilities and a $0.8 million related to the fiscal 2023 restructuring plan as noted below. During the third quarter of fiscal 2023, the Company initiated a restructuring plan to transform our business infrastructure and reduce our facilities footprint and the facilities related charges (the “2023 Plan”). As part of this project the Company will move engineering labs from its San Jose, California location to its Salem, New Hampshire location. This move is expected to help reduce the cost of operating our labs. The Company expects that the project will take about 18 to 24 months for completion and expects to incur charges of approximately $10.0 million throughout this period primarily for asset disposals, contractor costs, severance, relocation and other non-recurring fees. The Company recorded $0.4 million and $1.0 million of restructuring and related charges during the three and nine months ended March 31, 2022 which primarily included additional facility related expenses related to previously impaired facilities. The Company had minimal activity related to the 2020 Plan during the three months ended March 31, 2022. Severance and benefit restructuring charges consisted primarily of employee severance and benefit expenses incurred under the reduction-in-force action initiated in the third quarter of fiscal 2020 (the “2020 Plan”) to reduce operating costs and enhance financial flexibility as a result of disruptions caused by the COVID-19 global pandemic. With the reduction and realignment of the headcount under the 2020 Plan, the Company relocated certain of its lab test equipment to third-party consulting companies. The Company incurred $9.6 million of charges under the 2020 Plan and completed the 2020 Plan in the fourth quarter of fiscal 2022. As of June 30, 2022, the Company has no restructuring liabilities related to the 2020 Plan in the accompanying condensed consolidated balance sheets. Restructuring liabilities are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. As of March 31, 2023 the restructuring liability was $0.4 million related to the 2023 Plan and as of March 31, 2022, the restructuring liability was less than $0.1 million.

Restructuring and Related Charges

9 Months Ended

Mar. 31, 2023

Restructuring And Related Activities [Abstract]

14.

Restructuring and Related Charges

The Company recorded $1.4 million and $2.3 million of restructuring and related charges during the three and nine months ended March 31, 2023, respectively, which primarily included additional facilities charges related to previously impaired facilities and a $0.8 million related to the fiscal 2023 restructuring plan as noted below.

During the third quarter of fiscal 2023, the Company initiated a restructuring plan to transform our business infrastructure and reduce our facilities footprint and the facilities related charges (the “2023 Plan”). As part of this project the Company will move engineering labs from its San Jose, California location to its Salem, New Hampshire location. This move is expected to help reduce the cost of operating our labs. The Company expects that the project will take about 18 to 24 months for completion and expects to incur charges of approximately $10.0 million throughout this period primarily for asset disposals, contractor costs, severance, relocation and other non-recurring fees.

The Company recorded $0.4 million and $1.0 million of restructuring and related charges during the three and nine months ended March 31, 2022 which primarily included additional facility related expenses related to previously impaired facilities. The Company had minimal activity related to the 2020 Plan during the three months ended March 31, 2022. Severance and benefit restructuring charges consisted primarily of employee severance and benefit expenses incurred under the reduction-in-force action initiated in the third quarter of fiscal 2020 (the “2020 Plan”) to reduce operating costs and enhance financial flexibility as a result of disruptions caused by the COVID-19 global pandemic. With the reduction and realignment of the headcount under the 2020 Plan, the Company relocated certain of its lab test equipment to third-party consulting companies. The Company incurred $9.6 million of charges under the 2020 Plan and completed the 2020 Plan in the fourth quarter of fiscal 2022. As of June 30, 2022, the Company has no restructuring liabilities related to the 2020 Plan in the accompanying condensed consolidated balance sheets.

Restructuring liabilities are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. As of March 31, 2023 the restructuring liability was $0.4 million related to the 2023 Plan and as of March 31, 2022, the restructuring liability was less than $0.1 million.